Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy.

Thomas E. Witzig(WinnMed), Kenneth D. Bauer(CellaVision (Sweden)), Teresa K. Kimlinger, Blaise Bossy(Sanford Burnham Prebys Medical Discovery Institute), Douglas S. Harrington(CellaVision (Sweden)), Vera J. Suman(Mayo Clinic in Arizona), James N. Ingle(Mayo Clinic), Clive S. Grant(Mayo Clinic), Patrick C. Roche(Mayo Clinic), John H. Donohue(Columbus Community Clinical Oncology Program), Jose de la Torre-Bueno(CellaVision (Sweden))
PubMed
May 1, 2002
Cited by 156

Related Papers

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Whole-genome analysis informs breast cancer response to aromatase inhibition
|Nature|2012|1k
Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neurons
|The EMBO Journal|2006|649
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|546